Tupino, Bb Boy .
HRN: 23-53-21 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/16/2023
GENTAMICIN 40MG/ML, 2ML (AMP)
08/16/2023
08/22/2023
IV
18mg
OD
Neonatal Sepsis
Waiting Final Action
Indication: EmpiricEmpirical De-escalation Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes